Genfit S.A.
EPA:GNFT.PA
Overview | Financials
Company Name | Genfit S.A. |
Symbol | GNFT.PA |
Currency | EUR |
Price | 4.89 |
Market Cap | 243,561,120 |
Dividend Yield | 0% |
52-week-range | 2.9 - 5.86 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jean-Francois Mouney |
Website | https://www.genfit.com |
An error occurred while fetching data.
About Genfit S.A.
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD